Immunocore Holdings plc (IMCR)

NASDAQ: IMCR · Real-Time Price · USD

33.11

+0.34 (1.04%)

At close: Aug 1, 2025, 4:00 PM

32.99

-0.12 (-0.36%)

After-hours: Aug 1, 2025, 4:10 PM EDT

Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Operating Revenue	333.58	310.2	249.43	174.36	36.48	41.11	Upgrade
Revenue	333.58	310.2	249.43	174.36	36.48	41.11	Upgrade
Revenue Growth (YoY)	25.75%	24.37%	43.05%	377.91%	-11.26%	20.94%	Upgrade
Cost of Revenue	11.09	10.5	7.5	6.4	100.25	102.14	Upgrade
Gross Profit	322.49	299.7	241.92	167.96	-63.76	-61.02	Upgrade
Selling, General & Admin	156.69	155.78	144.5	123.06	110.82	62.45	Upgrade
Research & Development	213.39	214.38	157.08	96.61	-	-	Upgrade
Other Operating Expenses	-18.05	-18.05	0.9	-0.01	0.07	-2.19	Upgrade
Operating Expenses	352.03	352.11	302.47	219.66	110.9	60.26	Upgrade
Operating Income	-29.54	-52.41	-60.55	-51.7	-174.66	-121.28	Upgrade
Interest Expense	-18.63	-18.84	-5.15	-5.41	-5.57	-4.24	Upgrade
Interest & Investment Income	21.55	25.62	17.99	3.76	0.07	0.96	Upgrade
Currency Exchange Gain (Loss)	2.04	-3.45	-13.18	14.16	0.29	-	Upgrade
Other Non Operating Income (Expenses)	0.19	-	-	-	-	1.69	Upgrade
EBT Excluding Unusual Items	-24.39	-49.08	-60.89	-39.2	-179.88	-122.87	Upgrade
Gain (Loss) on Sale of Investments	5.47	-	-	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-	-1.45	Upgrade
Other Unusual Items	-3.85	-3.85	-	-1.69	-	5.05	Upgrade
Pretax Income	-22.77	-52.94	-60.89	-40.88	-179.88	-119.27	Upgrade
Income Tax Expense	-1.15	-1.85	-5.6	11.66	0.15	-18.11	Upgrade
Net Income	-21.63	-51.09	-55.29	-52.54	-180.03	-101.16	Upgrade
Net Income to Common	-21.63	-51.09	-55.29	-52.54	-180.03	-101.16	Upgrade
Shares Outstanding (Basic)	50	50	49	46	42	27	Upgrade
Shares Outstanding (Diluted)	50	50	49	46	42	27	Upgrade
Shares Change (YoY)	1.48%	2.25%	6.94%	7.59%	60.19%	18.95%	Upgrade
EPS (Basic)	-0.43	-1.02	-1.13	-1.15	-4.24	-3.81	Upgrade
EPS (Diluted)	-0.43	-1.02	-1.13	-1.15	-4.24	-3.81	Upgrade
Free Cash Flow	26.04	20.89	-2.49	-51.41	-144.49	-87.82	Upgrade
Free Cash Flow Per Share	0.52	0.42	-0.05	-1.13	-3.40	-3.31	Upgrade
Gross Margin	96.68%	96.61%	96.99%	96.33%	-174.77%	-148.42%	Upgrade
Operating Margin	-8.85%	-16.89%	-24.27%	-29.65%	-478.73%	-294.98%	Upgrade
Profit Margin	-6.48%	-16.47%	-22.17%	-30.14%	-493.45%	-246.04%	Upgrade
Free Cash Flow Margin	7.81%	6.73%	-1.00%	-29.49%	-396.04%	-213.60%	Upgrade
EBITDA	-25.49	-48.21	-56.46	-46.37	-167.07	-112.48	Upgrade
EBITDA Margin	-7.64%	-15.54%	-22.63%	-26.59%	-	-273.57%	Upgrade
D&A For EBITDA	4.05	4.2	4.09	5.34	7.59	8.8	Upgrade
EBIT	-29.54	-52.41	-60.55	-51.7	-174.66	-121.28	Upgrade
EBIT Margin	-8.85%	-16.89%	-24.27%	-29.65%	-	-294.98%	Upgrade
Revenue as Reported	333.58	310.2	249.43	174.36	36.48	41.11	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q